Ledger.Open graph →

SEC Form D · filed December 18, 2019

AZIYO BIOLOGICS, INC

Offering

$3.5M

Sold

$3.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SILVER SPRING, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Charles R. Mills · Silver Spring, MDDirector Kevin R. Rakin · Silver Spring, MDDirector Ronald D. Lloyd · Silver Spring, MDExec Jeffrey D. Hamet · Silver Spring, MDExec William M. Zuga · Silver Spring, MDDirector Gregory Link · Grand Cayman, Cayman IslandsDirector Andrew Sandler · New York, NYDirector Mark Lappe · La Jolla, CADirector Mitchell M. London · Redmond, WAExec Ralph Woodford · Grand Cayman, Cayman IslandsExec Steven R. Hotchberg · Silver Spring, MDDirector Ronald Shaich · Washington, Washington, D.C.Director William Burkoth · Ann Arbor, MIDirector Nicole Walker · Ann Arbor, MIExec Eric W. Jacobsen · Lake Oswego, ORDirector Kokila Doshi · San Diego, CAExec Steven R. Hotchberg · Silver Spring, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗